NorthWest Biotherapeutics Inc (NWBO)

[joeycav11]

The brilliance of Linda P is she keeps her eyes open for new innovations. Advent has from inception been open to accepting new clients in the cell therapy sector. The message that signals is they are open to innovation and technology sharing. They want to move this technology ahead and are willing to allow combination treatments.
Linda P is leaning towards the open sharing model. She will license our technology to companies with promising combination treatments that are willing to pay for clinical trials and regulatory approval
Her goal is to get this new treatment acknowledged and adopted for many indications and as quickly as possible .
And has she behind the scenes allowed our technology to be used in 8 and 6 year old trials that dstock has made us aware of?